📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

What are the research priorities for idiopathic intracranial hypertension? A priority setting partnership between patients and healthcare professionals. (2019)

First Author: Mollan S

Attributed to: MICA: Assessing the therapeutic efficacy of 11beta-hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) in idiopathic intracranial hypertension funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-026573

PubMed Identifier: 30878991

Publication URI: http://europepmc.org/abstract/MED/30878991

Type: Journal Article/Review

Volume: 9

Parent Publication: BMJ open

Issue: 3

ISSN: 2044-6055